Meropenem and Piperacillin Plasma Concentrations During CRRT
NCT04203784 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 135
Last updated 2019-12-19
Summary
This observational study reports meropenem and piperacillin plasma concentrations in patients treated with either antibiotic and simultaneous continuous renal replacement therapy (CRRT).
Conditions
Interventions
- OTHER
-
Plasma concentration measurements
Plasma concentration measurements
Sponsors & Collaborators
-
Karolinska University Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-11-01
- Primary Completion
- 2016-12-31
- Completion
- 2016-12-31
- FDA Drug
- Yes
Countries
- Sweden
Study Locations
More Related Trials
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Meropenem-Vaborbactam in Children With Complicated Urinary Tract Infection, Including Acute Pyelonephritis
NCT06672978 ·Status: RECRUITING ·Phase: PHASE2
-
Colistin Pharmacokinetics in Continuous Renal Replacement Therapy
NCT02081560 ·Status: UNKNOWN ·Phase: PHASE4
-
Best Available Therapy With or Without Meropenem for Bloodstream Infections by Enterobacterales With High Level of Resistance to Carbapenems
NCT04876430 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Assessment of the Optimal Dosing of Piperacillin-tazobactam in Intensive Care Unit Patients: Extended Versus Continuous Infusion
NCT01198925 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics of Antibiotics in Patients Undergoing Renal Replacement Therapies
NCT03636464 ·Status: RECRUITING
-
Population Pharmacokinetics of Commonly Used Antimicrobial Agents in Children of Bacterial Meningitis With Augmented Renal Clearance
NCT04771884 ·Status: RECRUITING
-
Antibiotic Durations for Gram-negative Bacteremia
NCT03101072 ·Status: COMPLETED ·Phase: NA
-
Dose-finding, Pharmacokinetics, and Safety of VABOMERE in Pediatric Subjects With Bacterial Infections
NCT02687906 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Pragmatic Clinical Trial Comparing the Risk of Acute Kidney Injury During Treatment With Vancomycin and Piperacillin-Tazobactam vs. Vancomycin and Cefepime in Hospitalized Patients
NCT06954129 ·Status: RECRUITING ·Phase: PHASE4
-
A Dried Blood Spot Sampling Method for Vancomycin and Creatinine Monitoring for OPAT
NCT06283433 ·Status: RECRUITING ·Phase: NA
-
Optimized Antibiotic Therapy in Patients With Subarachnoid Haemorrhage (ES) and Cerebral Haemorrhage (EC)
NCT04132115 ·Status: UNKNOWN
-
Pharmacokinetics and Safety of Piperacillin-tazobactam in Neonates
NCT00873327 ·Status: COMPLETED ·Phase: PHASE1
-
Retrospective Observational Study of Cotrimoxazole Dosing in Intensive Care Unit
NCT05221216 ·Status: COMPLETED
-
Evaluation of the Dialytic Clearance of the Combination of Peracillin and Tazobactam
NCT07167524 ·Status: NOT_YET_RECRUITING
-
Extended-infusion of Piperacillin-Tazobactam Versus Intermittent Infusion
NCT04895657 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetic (PK) and Safety Study of Meropenem in Young Infants With Intra-abdominal Infections
NCT00621192 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Precision Dosing of Beta-lactam Antibiotics in Critically Ill Children
NCT06929702 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Imipenem/Cilastatin/Relebactam (IMI/REL) in Treatment of CRE Infections
NCT04785924 ·Status: WITHDRAWN ·Phase: PHASE4
-
Validation of Betalactam ML Prediction Models - TDMAide
NCT06026852 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Pilot Study for Optimizing Meropenem Administration in the ICU
NCT05578586 ·Status: RECRUITING ·Phase: NA
-
Pharmacokinetics of Antibiotics in Critically Ill Patients Receiving CVVHF
NCT04800952 ·Status: UNKNOWN ·Phase: NA
-
Outpatient Parenteral Antibiotic Therapy in the Metropolitan Area of Cologne
NCT04002453 ·Status: UNKNOWN
-
Comparative Study of Ertapenem Versus Another Antibiotic in the Treatment of Diabetic Foot Infections in Adults (0826-034)
NCT00229112 ·Status: COMPLETED ·Phase: PHASE3
-
Antibiotic Dosing in Pediatric Intensive Care
NCT02456974 ·Status: RECRUITING
-
AbioKin - Antibiotic Kinetics
NCT02609646 ·Status: COMPLETED